Routine Thyroid Swellings Show 14% Malignancy Rate, with Higher Risk in Males and Extreme Age Groups, Study Finds
A recent cross-sectional study published in the International Journal of Otorhinolaryngology and Head and Neck Surgery in August 2026 reveals a striking 14.0% malignancy rate among routine thyroid swellings. These findings offer crucial diagnostic insights, highlighting that males and individuals at extreme ages face a significantly higher risk of hidden thyroid cancer.
While the exact rate of thyroid cancer in resource-limited areas remains unclear due to a lack of comprehensive population registries. To address this gap, Dr. Muhammad Kamrul Hasan and colleagues studied patients in a tertiary care setting to determine the precise incidence of malignancy among thyroid swellings.
Therefore, the researchers evaluated 50 patients with thyroid swellings at Rajshahi Medical College Hospital to determine malignancy rates. The team used a combination of clinical exams, ultrasounds, and cytology, ultimately relying on histopathology to confirm the final diagnosis.
Key Clinical Findings of the Study Includes:
Demographic Distribution: Analysis revealed a strong female preponderance comprising 84% of presentations, primarily clustered within the 31 to 40-year age bracket.
Malignancy Risks: Researchers noted that despite higher female presentation volumes, males exhibited a significantly elevated malignancy rate of 25.0% compared to 11.9% in females, alongside peak incidences in extreme age demographics.
Histological Patterns: Investigators found that papillary carcinoma overwhelmingly dominated the malignant spectrum, accounting for 85.7% of all confirmed cancers.
Clinical Indicators: Evidence demonstrated that shorter symptom durations of under two years and the presence of solid sonographic nodules were frequently associated with malignant pathology.
The results suggest that a substantial 14.0% of hospitalized patients presenting with thyroid swellings harbor an underlying malignancy. These findings highlight that both gender and age extremes are critical determinants in assessing the malignant potential of these common endocrine presentations.
Thus, the study concludes healthcare professionals might consider adopting a slightly more vigilant diagnostic approach, ensuring careful evaluation and prompt medical attention, particularly when managing male patients or those in extreme age brackets presenting with goiter.
While the small sample size and short duration within a single tertiary center present certain limitations, these initial insights gracefully pave the way for larger, population-based demographic studies to more comprehensively capture the true nationwide incidence of thyroid malignancy.
Reference
Hasan MK, Rashid MH, Islam MN, Forhad R, Shishir RA, Uddin S. Incidence of malignancy among thyroid swellings. Int J Otorhinolaryngol Head Neck Surg. 2026;12(4):505-511..
